JP2006526638A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526638A5
JP2006526638A5 JP2006514964A JP2006514964A JP2006526638A5 JP 2006526638 A5 JP2006526638 A5 JP 2006526638A5 JP 2006514964 A JP2006514964 A JP 2006514964A JP 2006514964 A JP2006514964 A JP 2006514964A JP 2006526638 A5 JP2006526638 A5 JP 2006526638A5
Authority
JP
Japan
Prior art keywords
configuration
line represents
phenyl
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006514964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006526638A (ja
Filing date
Publication date
Priority claimed from US10/453,207 external-priority patent/US6734206B1/en
Application filed filed Critical
Publication of JP2006526638A publication Critical patent/JP2006526638A/ja
Publication of JP2006526638A5 publication Critical patent/JP2006526638A5/ja
Pending legal-status Critical Current

Links

JP2006514964A 2003-06-02 2004-05-25 眼圧降下剤としての3−オキサ−8−アザプロスタグランジン類似体 Pending JP2006526638A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/453,207 US6734206B1 (en) 2003-06-02 2003-06-02 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
PCT/US2004/016516 WO2004108670A1 (en) 2003-06-02 2004-05-25 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure

Publications (2)

Publication Number Publication Date
JP2006526638A JP2006526638A (ja) 2006-11-24
JP2006526638A5 true JP2006526638A5 (https=) 2007-07-12

Family

ID=32230466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006514964A Pending JP2006526638A (ja) 2003-06-02 2004-05-25 眼圧降下剤としての3−オキサ−8−アザプロスタグランジン類似体

Country Status (10)

Country Link
US (1) US6734206B1 (https=)
EP (1) EP1638936B1 (https=)
JP (1) JP2006526638A (https=)
AT (1) ATE496886T1 (https=)
AU (1) AU2004245492B2 (https=)
BR (1) BRPI0410926A (https=)
CA (1) CA2528010C (https=)
DE (1) DE602004031225D1 (https=)
ES (1) ES2358513T3 (https=)
WO (1) WO2004108670A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734201B1 (en) * 2003-06-02 2004-05-11 Allergan, Inc. 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
US7863318B2 (en) * 2005-11-03 2011-01-04 Allergan, Inc. Prostaglandins and analogues as agents for lowering intraocular pressure
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8783923B2 (en) * 2010-03-18 2014-07-22 Chung Yuan Christian University Auto lamp structure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
AU2211700A (en) * 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
GEP20043203B (en) * 1999-12-22 2004-03-25 Pfizer Prod Inc EP4 Receptor Selective Agonists in the Treatment of Osteoporosis
IL141120A0 (en) 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
US20010056060A1 (en) 2000-02-07 2001-12-27 Cameron Kimberly O. Treatment of osteoporsis with EP2/EP4 receptor selective agonists
JP4063468B2 (ja) 2000-02-22 2008-03-19 株式会社カネボウ化粧品 寒天被覆処理顔料およびメイクアップ化粧料
AU2001290250A1 (en) 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
OA12533A (en) 2000-11-27 2006-06-05 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis.
JP4520738B2 (ja) * 2001-06-14 2010-08-11 アラーガン インコーポレイテッド 眼圧降下剤としての3、7、または3および7チアまたはオキサプロスタン酸誘導体
CA2451392A1 (en) * 2001-07-16 2003-01-30 F. Hoffmann-La Roche Ag Prostaglandin analogues as ep4 receptor agonists
CN100371322C (zh) 2001-07-16 2008-02-27 霍夫曼-拉罗奇有限公司 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物
EP2255829A3 (en) 2001-07-23 2012-03-28 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
EP1490055A1 (en) * 2002-03-18 2004-12-29 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists

Similar Documents

Publication Publication Date Title
CA2485850A1 (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP7249374B2 (ja) 眼疾患を処置するための組成物、製剤、および方法
CN103497148B (zh) 羟胺化合物及其用法
TW518220B (en) Hair growth composition using neuroimmunophilin FKBP ligands
AU2010212339B2 (en) Composition comprising a JNK inhibitor and cyclosporin
US20070093492A1 (en) Pyrrolidine derivatives
JP2004529166A5 (https=)
US20080255094A1 (en) Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
WO2006022428A1 (ja) 糖尿病治療剤
CN107266433A (zh) sGC刺激剂
JP2002501049A5 (https=)
EP1666067A1 (en) Drug containing chymase inhibitor as the active ingredient
JP2008502614A5 (https=)
TW200305425A (en) 8-Azaprostaglandin derivatives and medicament containing same as active ingredient
CN107406421A (zh) sGC刺激物
NZ597528A (en) Inhibitors of flaviviridae viruses
US20070010529A1 (en) Nitrogenous heterocyclic compounds and medical use thereof
JP2006160733A (ja) シアノフルオロピロリジン誘導体を有効成分として含有する医薬
CN102803214A (zh) 新化合物、与之相关的药物组合物和方法
RU2006101553A (ru) Новые соединения, которые модулируют рецепторы типа ppary, и их применение в косметических и фармацевтических композициях
JPWO2005063704A1 (ja) アゼチジン環化合物およびその医薬
CA2446386A1 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
JP2004530687A5 (https=)
JPWO2004101514A1 (ja) シアノフルオロピロリジン誘導体
RU2007128085A (ru) Соли четвертичного аммония в качестве антагонистов м3